Robert Ross is the founder of Surface Oncology. Surface Oncology has raised $150M in total funding. Latest round: Series A. Based in Cambridge, Massachusetts.
Robert Ross, MD, is the Chief Executive Officer of Clasp Therapeutics, an immuno-oncology company co-located in Cambridge and Rockville, Maryland. Clasp Therapeutics recently launched with a $150 million Series A funding round. Prior to Clasp Therapeutics, Ross was the CEO and a board member of Surface Oncology, Inc. before its acquisition, and also served as Head of Oncology at bluebird bio, Inc.
Full founder directory · Investor directory · Company funding database · Fundraising library